Index by author
September 01, 2012; Volume 79,Issue 9
Chamsi-pasha, Mohammed
- You have accessThe role of aldosterone receptor antagonists in the management of heart failure: An updateVijaiganesh Nagarajan, MD, Mohammed Chamsi-Pasha, MD and W. H. Wilson Tang, MDCleveland Clinic Journal of Medicine September 2012, 79 (9) 631-639; DOI: https://doi.org/10.3949/ccjm.79a.12014
Spironolactone (Aldactone) and eplerenone (Inspra) are now part of standard therapy. Still, they must be used cautiously, as they can cause hyperkalemia.